These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 9052859)

  • 41. Src homology 2 domain-containing protein-tyrosine phosphatases, SHP-1 and SHP-2, are required for platelet endothelial cell adhesion molecule-1/CD31-mediated inhibitory signaling.
    Henshall TL; Jones KL; Wilkinson R; Jackson DE
    J Immunol; 2001 Mar; 166(5):3098-106. PubMed ID: 11207261
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The src homology 2-containing inositol phosphatase (SHIP) is the gatekeeper of mast cell degranulation.
    Huber M; Helgason CD; Damen JE; Liu L; Humphries RK; Krystal G
    Proc Natl Acad Sci U S A; 1998 Sep; 95(19):11330-5. PubMed ID: 9736736
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Regulation of high-affinity IgE receptor-mediated mast cell activation by murine low-affinity IgG receptors.
    Daëron M; Malbec O; Latour S; Arock M; Fridman WH
    J Clin Invest; 1995 Feb; 95(2):577-85. PubMed ID: 7860741
    [TBL] [Abstract][Full Text] [Related]  

  • 44. SHIP down-regulates FcepsilonR1-induced degranulation at supraoptimal IgE or antigen levels.
    Gimborn K; Lessmann E; Kuppig S; Krystal G; Huber M
    J Immunol; 2005 Jan; 174(1):507-16. PubMed ID: 15611277
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Molecular basis of the recruitment of the SH2 domain-containing inositol 5-phosphatases SHIP1 and SHIP2 by fcgamma RIIB.
    Bruhns P; Vely F; Malbec O; Fridman WH; Vivier E; Daeron M
    J Biol Chem; 2000 Dec; 275(48):37357-64. PubMed ID: 11016922
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Tyrosine phosphorylation is required for mast cell activation by Fc epsilon RI cross-linking.
    Kawakami T; Inagaki N; Takei M; Fukamachi H; Coggeshall KM; Ishizaka K; Ishizaka T
    J Immunol; 1992 Jun; 148(11):3513-9. PubMed ID: 1375248
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Protein-tyrosine phosphatase SHP-1 is dispensable for FcgammaRIIB-mediated inhibition of B cell antigen receptor activation.
    Nadler MJ; Chen B; Anderson JS; Wortis HH; Neel BG
    J Biol Chem; 1997 Aug; 272(32):20038-43. PubMed ID: 9242674
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The role of SHIP in mast cell degranulation and IgE-induced mast cell survival.
    Huber M; Kalesnikoff J; Reth M; Krystal G
    Immunol Lett; 2002 Jun; 82(1-2):17-21. PubMed ID: 12008029
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Positive and negative regulation of mast cell activation by Lyn via the FcepsilonRI.
    Xiao W; Nishimoto H; Hong H; Kitaura J; Nunomura S; Maeda-Yamamoto M; Kawakami Y; Lowell CA; Ra C; Kawakami T
    J Immunol; 2005 Nov; 175(10):6885-92. PubMed ID: 16272347
    [TBL] [Abstract][Full Text] [Related]  

  • 50. SH2 domain-containing phosphatase-2 protein-tyrosine phosphatase promotes Fc epsilon RI-induced activation of Fyn and Erk pathways leading to TNF alpha release from bone marrow-derived mast cells.
    McPherson VA; Sharma N; Everingham S; Smith J; Zhu HH; Feng GS; Craig AW
    J Immunol; 2009 Oct; 183(8):4940-7. PubMed ID: 19786542
    [TBL] [Abstract][Full Text] [Related]  

  • 51. SHIP negatively regulates IgE + antigen-induced IL-6 production in mast cells by inhibiting NF-kappa B activity.
    Kalesnikoff J; Baur N; Leitges M; Hughes MR; Damen JE; Huber M; Krystal G
    J Immunol; 2002 May; 168(9):4737-46. PubMed ID: 11971024
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The Src homology 2 domain-containing inositol 5-phosphatase negatively regulates Fcgamma receptor-mediated phagocytosis through immunoreceptor tyrosine-based activation motif-bearing phagocytic receptors.
    Nakamura K; Malykhin A; Coggeshall KM
    Blood; 2002 Nov; 100(9):3374-82. PubMed ID: 12384440
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Fcgamma receptor-mediated inhibition of human B cell activation: the role of SHP-2 phosphatase.
    Koncz G; Pecht I; Gergely J; Sármay G
    Eur J Immunol; 1999 Jun; 29(6):1980-9. PubMed ID: 10382761
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Src homology 2 domain-containing inositol polyphosphate phosphatase regulates NF-kappa B-mediated gene transcription by phagocytic Fc gamma Rs in human myeloid cells.
    Tridandapani S; Wang Y; Marsh CB; Anderson CL
    J Immunol; 2002 Oct; 169(8):4370-8. PubMed ID: 12370370
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Positive regulation of c-Jun N-terminal kinase and TNF-alpha production but not histamine release by SHP-1 in RBL-2H3 mast cells.
    Xie ZH; Zhang J; Siraganian RP
    J Immunol; 2000 Feb; 164(3):1521-8. PubMed ID: 10640770
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The role of SHIP in the development and activation of mouse mucosal and connective tissue mast cells.
    Ruschmann J; Antignano F; Lam V; Snyder K; Kim C; Essak M; Zhang A; Lin AH; Mali RS; Kapur R; Krystal G
    J Immunol; 2012 Apr; 188(8):3839-50. PubMed ID: 22430739
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Down-regulation of protein-tyrosine phosphatases activates an immune receptor in the absence of its translocation into lipid rafts.
    Heneberg P; Dráberová L; Bambousková M; Pompach P; Dráber P
    J Biol Chem; 2010 Apr; 285(17):12787-802. PubMed ID: 20157115
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Superclustering of B cell receptor and Fc gamma RIIB1 activates Src homology 2-containing protein tyrosine phosphatase-1.
    Sato K; Ochi A
    J Immunol; 1998 Sep; 161(6):2716-22. PubMed ID: 9743328
    [TBL] [Abstract][Full Text] [Related]  

  • 59. IgE-Fc epsilonRI-mast cell axis in the allergic cycle.
    Pawankar R; Ra C
    Clin Exp Allergy; 1998 Aug; 28 Suppl 3():6-14. PubMed ID: 9756181
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Monomer hapten and hapten-specific IgG inhibit mast cell activation evoked by multivalent hapten with different mechanisms.
    Suzuki R; Inoh Y; Yokawa S; Suzuki R; Furuno T; Hirashima N
    Eur J Immunol; 2019 Dec; 49(12):2172-2183. PubMed ID: 31339552
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.